Estimate Recalculated Apr 2, 2025 09:11PM EST
Karin Eastham has an estimated net worth of $21.9 Million. This is based on reported shares across multiple companies, which include ILLUMINA INC, SGX PHARMACEUTICALS, INC., TERCICA INC, GERON CORP, Trius Therapeutics Inc, VERACYTE, INC., GENOPTIX INC, NEKTAR THERAPEUTICS, Personalis, Inc., AMYLIN PHARMACEUTICALS INC, and DIVERSA CORP.
Karin Eastham's CIK is 0001231845
2011 was Karin Eastham's most active year for acquiring shares with 15 total transactions. Karin Eastham's most active month to acquire stocks was the month of April. 2004 was Karin Eastham's most active year for disposing of shares, totalling 38 transactions. Karin Eastham's most active month to dispose stocks was the month of December. 2017 saw Karin Eastham paying a total of $817,128.00 for 73,105 shares, this is the most they've acquired in one year. In 2017 Karin Eastham cashed out on 22,741 shares for a total of $2,306,690.49, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!